Pericardial Effusion Management

Diagnostic Approach

The European Society of Cardiology recommends transthoracic echocardiography as the first-line diagnostic tool for all patients with suspected pericardial effusion 1, 3
Assessment of inflammatory markers is essential to determine if the effusion is associated with systemic inflammation, according to the European Heart Journal 1, 3
Chest X-ray should be performed in all patients with suspected pericardial effusion to evaluate for pleuropulmonary involvement, as suggested by the European Heart Journal 1
CT or CMR should be considered as second-level imaging techniques when loculated effusion, pericardial thickening, masses, or associated chest abnormalities are suspected, as recommended by the European Heart Journal 1, 3

For pericardial effusion with associated inflammation/pericarditis, the European Heart Journal recommends first-line therapy with NSAIDs (aspirin/ibuprofen) plus colchicine 1, 3, 4
The European Heart Journal suggests second-line therapy with corticosteroids for patients with contraindications or failure of first-line therapy 1, 3
For refractory cases, the European Heart Journal recommends considering adding azathioprine or cyclophosphamide 5, 6
For isolated pericardial effusion without inflammation, treatment should target the underlying cause when identified, as recommended by the European Heart Journal 1, 3
Drainage procedures are indicated for cardiac tamponade, symptomatic moderate to large effusions not responsive to medical therapy, or suspected bacterial or neoplastic etiology, according to the European Heart Journal 1, 2

Pericardiocentesis with echocardiographic or fluoroscopic guidance is the preferred initial approach for most effusions requiring drainage, as suggested by the European Heart Journal 5, 6
Prolonged pericardial drainage may be considered to promote pericardial layer adherence, as recommended by the European Heart Journal 1
For recurrent effusions, the European Heart Journal suggests considering pericardial window or pericardiectomy 1, 5, 6

For tuberculous pericarditis, the European Heart Journal recommends standard anti-TB drugs for 6 months to prevent constrictive pericarditis 2
For malignant effusions, the European Heart Journal suggests systemic antineoplastic treatment as baseline therapy, and considering intrapericardial instillation of cytostatic/sclerosing agents 3

Small asymptomatic effusions generally have good prognosis and may not require specific monitoring, as suggested by the European Heart Journal 3, 7
Moderate idiopathic effusions should be followed with echocardiography every 6 months, as recommended by the European Heart Journal 3
Large chronic effusions require more vigilant monitoring due to 30-35% risk of progression to cardiac tamponade, according to the European Heart Journal 3